AndrewTTurrisi IiiIIIMD

PubMed

• 99 citations
  Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline
  Charles B. Simone, Jeffrey A. Bogart, Alvin R. Cabrera, Megan E. Daly, Nicholas J. DeNunzio, Frank C. Detterbeck, Corinne Faivre-Finn, Nancy Gatschet, Elizabeth Gore, ...> ;Practical Radiation Oncology. 2020 May 1
• 24 citations
  Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Data...
  Shaakir Hasan, Paul Renz, Andrew T. Turrisi, Athanasios Colonias, Gene Grant Finley, Rodney E. Wegner> ;Lung Cancer. 2018 Aug 20
• The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell...
  Andrew Turrisi Iii III, MD> ;Journal of Thoracic Oncology. 2016 Jan 03
• Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.
  Albain KS Swann RS Rusch VW Turrisi AT 3rd Shepherd FA Smith C Chen Y Livingston RB Feins RH Gandara DR Fry WA Darling G Johnson DH Green MR Miller RC Ley J Sause WT C...> ;Lancet . 2009 Aug 1
• 1 citations
  A case against surgery for most IIIa non-small cell lung cancer.
  Andrew T. Turrisi> ;Seminars in Oncology. 2005 Apr 1
• 2 citations
  Southwest Oncology Group: two decades of experience in non-small cell lung cancer.
  Andrew T. Turrisi, John Crowley, Kathy S. Albain, Laurie E. Gaspar, David R. Gandara> ;Seminars in Oncology. 2005 Apr 1
• 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
  Bogart JA Herndon JE 2nd Lyss AP Watson D Miller AA Lee ME Turrisi AT Green MR > ;Int J Radiat Oncol Biol Phys . 2004 Jun 1
• Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).
  Lyss AP Herndon JE 2nd Lynch TJ Jr Turrisi AT Watson DM Grethlein SJ Green MR > ;Clin Lung Cancer . 2002 Feb
• Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].
  Mitas M Hoover L Silvestri G Reed C Green M Turrisi AT Sherman C Mikhitarian K Cole DJ Block MI Gillanders WE > ;J Mol Diagn . 2003 Nov
• The role of radiotherapy and chemotherapy for curative management of medically inoperable and stage III nonsmall cell lung cancer, and radiotherapy for palliation of s...
  Turrisi AT 3rd Bogart J Sherman C Silvestri G > ;Respir Care Clin N Am . 2003 Jun
• Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer.
  Scagliotti GV Turrisi AT 3rd > ;Oncologist . 2003
• Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.
  Albain KS Crowley JJ Turrisi AT 3rd Gandara DR Farrar WB Clark JI Beasley KR Livingston RB > ;J Clin Oncol . 2002 Aug 15
• Join now to see all

Journal Articles

• Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin etoposide: A randomized Intergroup stu...  
  Turrisi AT, Kim K, Blum R et al., New England Journal of Medicine, 1/1999
• The Elderly Cancer Patient: Radiotherapy Issues.  
  Turrisi AT, RAYS – International Journal of Radiological Sciences 24 (Suppl to II):17-21
• Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.  
  Miles EF, Larrier NA, Kelsey CR, et al, Int J Radiat Oncol Biol Phys; 71(4): 1143-50
• Limited Small-Cell Lung Cancer: A Potentially Curable Disease.  
  Sherman CA, Rocha-Lima, CM, Turrisi AT, Oncology 13(10):1395-1409
• Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee.  
  Buyyounouski MK, Balter P, Lewis B, et al, Int J Radiat Oncol Biol Phys;78(1): 3-10
• Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer.  
  Felip E, Rosell R, MAESTRE JA, et al, J Clin Oncol; 28(19): 3138-45
• Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomi...  
  Pisters KM, Vallieres E, Crowley JJ, et al, J Clin Oncol; 28(11): 1843-9
• Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation.  
  Williams TE. Thomas CR Jr. Turrisi AT 3rd, Seminars in Radiation Oncology. 10(4):315-23
• Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy f...  
  Bradley JD, Bae K, Graham MV, et al, J Clin Oncol; 28(14): 2475-80
• Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.  
  AUPERIN A, Le Pechoux C, ROLLAND E, et al, J Clin Oncol; 28(13): 2181-90
• Locally advanced esophageal cancer.  
  Sherman CA, Turrisi AT, Wallace MB, Reed CE, Curr Treat Options Oncol; 3(6):475-85
• Detterbeck FCA systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage.  
  de Cabanyes Candela S, J Thorac Oncol; 5(3): 389-98
• Radiation-induced reductions in regional lung perfusion: 0.1-12 year data from a prospective clinical study.  
  Zhang J, Ma J, Zhou S, et al, Int J Radiat Oncol Biol Phys; 76(2): 425-32
• The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.  
  Ignatius Ou SH, ZELL JA, J Thorac Oncol; 4(3): 300-10
• Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy ...  
  Le Pechoux C, DUNANT A, Senan S, et al, Lancet Oncol;10(5): 467-74
• Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.  
  Socinski MA, SMIT EF, Lorigan P, et al, J Clin Oncol; 27(28): 4787-92
• Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.  
  Rammela S, Trodella L, Mineo TC, et al, Int J Radiat Oncol Biol Phys; 76(1): 110-5
• Radiation-induced reductions in regional lung perfusion: 0.1-12 year data from a prospective clinical study.  
  Zhang J, Ma J, Zhou S, et al, Int J Radiat Oncol Biol Phys; 76(2): 425-32
• Limited stage small cell lung cancer: treatment and therapy.  
  Turrisi AT, Current Treatment Option in Oncology 4(1): 61-64
• Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lu...  
  Hanna N, Neubauer M, Yiannoutsos C, et al, Oncology.J Clin Oncol; 26(35): 5755-60
• Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.  
  Chang JY, Balter PA, Dong L, et al, Int J Radiat Oncol Biol Phys; 72(4): 967-71
• Southwest Oncology Group: two decades of experience in non-small cell lung cancer.  
  Turrisi AT, Crowley J, Albain K, Gaspar L, Gandara D, Semin Oncol; 32(2 Suppl 3):S119-21
• High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after inducti...  
  Arrieta O, Gallardo-Rincon D, Villarreal-Garza C, et al, J Thorac Oncol; 4(7): 845-52
• Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.  
  Bogart JA, Hodgson L, Seagren SL, et al, J Clin Oncol; 28(2): 202-6
• Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.  
  Ramella S, Trodella L, Mineo TC, et al, Int J Radiat Oncol Biol Phys; 76(1): 110-5
• Join now to see all

Books/Book Chapters

• Lung Cancer: Principles and Practice. 
  Pass HI, Mitchell J, Johnson DH, Turrisi ATLippincott-Raven, Philadelphia
• Lung Cancer: Principles and Practice. 
  Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JDLippincott Williams & Wilkins, PhiladelphiaEdition 2nd,
• Lung Cancer Principles and Practice. 
  Pass H, Johnson D, Carbone D, Minna JD, Turrisi ATEditors: Ang KK, Glatstein E, Halperin EC, Harris JR, Lawton CA, Martinez AA, Shaw EG, Turrisi ATT.Lippincott Williams & Wilkins, PhiladelphiaEdition 3rd,
• Lung cancer Principles and Practice. 
  Pass H. Carbone D, Johnson DH, Minna JD, Scagliotti GV; Turrisi, ATEdition 4th,
• The role of bleomycin in the treatment of advanced head and neck cancer. 
  Turrisi AT, Rozenzweig M. Von Hoff DD, Muggia FMEditors: Carter, Crooke and Umezawa.Academic Press, San Francisco
• Bone Tumours and Soft-Tissue Sarcomas. 
  Chapter: Soft-tissue and bone sarcomas in adults 
  Turrisi AT, D'Angio GJEditors: G.J. D'Angio and A.E. Evans.Edward Arnold Ltd
• Treatment Modalities in Lung Cancer Antibiot Chemother. 
  Chapter: Concurrent twice-daily radiotherapy plus Platinum-Etoposide chemotherapy for the treatment of limited small cell lung cancer: A preliminary report 
  Page 109 - 114Turrisi AT, Glover DJ, Mason BAEditors: Arriagada, R. Basel, Karger.
• Radiation Oncology Rationale, Technique, Results. 
  Chapter: Principles of combined-modality therapy: Progress, prospects and problems 
  Turrisi AT, Glatstein EEditors: W.T. Moss and J.D. Cox.C.V. Mosby Company, St. Louis
• Management of Small Cell Lung Cancer. 
  Chapter: Thoracic radiation therapy: Dosage and techniques 
  Page 130 - 135Turrisi ATElsevier Science Publishers, The Netherlands
• Cancer Chemotherapy: Principles and Practice. 
  Chapter: Radiation and chemotherapy sensitizers and protectors 
  Coleman CN, Glover DJ, Turrisi ATEditors: B.A. Chabner, J.M. Collins, and C.E. Myers.J.B. Lippincott Company, Philadelphia, PA
• Medical Radiology, Concomitant Continuous Infusion Chemotherapy and Radiation. 
  Chapter: Small cell carcinoma of the lung 
  Page 217 - 221Turrisi ATEditors: Marvin Rotman/C. Julian Rosenthal.Spring-Verlag, New York
• ESO Monographs, Current Topics in Lung Cancer. 
  Chapter: Combined modality therapy for limited small cell lung cancer 
  Turrisi ATEditors: Paul A. Bunn, Jr., M.D.Springer-Verlag, New York
• Current Topics in Lung Cancer. 
  Chapter: Radiotherapy for non-small cell lung cancer 
  Turrisi ATEditors: P.A. Bunn, Jr., M.D.Springer-Verlag, New York
• Current Topics in Lung Cancer. 
  Chapter: Cranial Irradiation 
  Turrisi ATEditors: P.A. Bunn, Jr., M.D.Springer-Verlag, New York
• Cancer Medicine 3rd Edition. 
  Chapter: Neoplasms of the thorax 
  Holmes EC, Livingston R, Turrisi ATEditors: James F. Holland, et al.Lea & Febiger, PA
• Lung Cancer. 
  Chapter: Lung cancer: chemoradiotherapy options 
  Page 222 - 236Turrisi ATEditors: Jack A. Roth, James D Cox and Waun K. Hong.Blackwell Scientific Publications, Massachusetts
• Chemoradiation: an integrated approach to cancer treatment. 
  Chapter: Small-cell carcinoma of the lung 
  Page 347 - 360Turrisi AT, Johnson DH, Comis RLEditors: Madhu J. John, et. al.Lea & Febiger, PA
• Lung Cancer: Frontiers in Science and Treatment. 
  Chapter: Neoadjuvant therapy in locally advanced lung cancer: A perspective from radiation oncology 
  Page 645 - 655Hazuka MB, Turrisi ATEditors: Giovannia Motta. Grafica L.P.Genoa, Italy
• Cancer Treatment. 
  Chapter: Non-small cell lung cancer 
  Page 385 - 413Figlin RA, Holmes EC, Turrisi ATEditors: Haskell C.WB Saunders, Philadelphia
• Surgery of the Alimentary Tract, Vol I - The Esophagus. 
  Chapter: Radiation therapy in the treatment of carcinoma of the esophagus 
  Turrisi ATEditors: Zuidema GD, Orringer MB.W.B. Saunders, PhiladelphiaEdition 4th,
• Lung Cancer: Principles and Practice. 
  Chapter: Principles and Application of Preoperative and Standard Radiotherapy for Regionally Advanced Non-small Cell Lung Cancer 
  Sause WT and Turrisi ATEditors: Pass HI, Mitchell JB, Johnson DH, Turrisi AT.Lippincott-Raven, Philadelphia
• Lung Cancer Principles and Practice. 
  Chapter: Combined Modality Treatment for Locally Advanced Non-Small Cell Lung Cancer 
  Johnson DH, Turrisi AT, Pass HIEditors: Pass HI, Mitchell JB, Johnson DH and Turrisi AT eds.Lippincott-Raven, Philadelphia
• Lung Cancer. 
  Chapter: Radiation therapy: Its role in the treatment of limited disease small cell lung cancer 
  Page 128 - 135Turrisi ATArnold
• Radiation Injury, Advances in Management and Prevention.” Frontiers of Radiation Therapy and Oncology. 
  Chapter: Lung toxicity in the treatment of lung cancer: Thoughts at the end of the millennium 
  Page 63 - 70Thomas CR, Williams TE, Turrisi ATEditors: Meyer JL.Basel, Karger
• Clinical Radiation Oncology. 
  Chapter: Overview of Thoracic Oncology 
  Thomas CR, Turrisi ATEditors: Gunderson LL, Tepper JE.Churchill Livingston, New YorkEdition 1st,
• Join now to see all

Abstracts/Posters

• Concurrent twice daily thoracic radiotherapy (BID-TRT) and Platinum-Etoposide (PE) chemotherapy in limited cell lung cancer (LSCLC).
  Turrisi AT, Glover DJ, Mason B, 15th International Cancer Conference, Hamburg, Germany
• Prophylactic cranial irradiation (PCI) given at completion of systemic therapy for LSCLC: Analysis of long term follow-up.
  Turrisi AT, Glover DJ, 15th International Cancer Conference, Hamburg, Germany
• Controversies in the treatment of NSCLC with radiotherapy.
  Turrisi AT, Lung Cancer, 6(5-6)
• Eastern Cooperative Oncology Group, : Alternating accelerated radiation therapy (RT) and chemotherapy (CT) with Cisplatin-Etoposide in stage III no-small cell lung ca...
  Wagner H Jr., Johnson DH, Turrisi AT, Crocker I, Hernandez B, ASCO, 9:247, Albany, NY
• Limited small cell lung cancer (LSCLC): Concurrent BID thoracic radiotherapy (TR) with platinum-etoposide (PE): An ECOG Study.
  Turrisi AT, Wagner H, Glover B, Bason B, Oken M, Bonomi P, Proceedings of ASCO, 9:230
• Alternating chemotherapy (CT) and thoracic radiotherapy (TRT) in limited small cell lung cancer (LSCLC): A trial of the Looney hypothesis.
  Johnson DH, Turrisi AT, Change SY, Wagner R, Blum R, for the ECOG, Proceedings of ASCO, 10:243
• Interdigitated therapy of patients with stage IIIA and IIIB non-small cell lung cancer with alternating course of BID thoracic irradiation (T10 and Chemotherapy (CT) w...
  Wagner Jr H, Johnson DH, Turrisi AT for the Eastern Cooperative Oncology Group, 6th World Conference on Lung Cancer, Melbourne, Australia
• Alternating chemotherapy (CT) thoracic radiotherapy (TRT) in limited small cell lung cancer.
  Turrisi AT, Chang AY, Wagner H, Blum R, for the Eastern Cooperative Oncology Group, 6th World Conference on Lung Cancer, Melbourne, Australia
• Long-term results of Platinum-Etoposide (PE) plus twice-daily (BID) thoracic radiotherapy (TRT) for limited small cell lung cancer (LSCLC): Results on 32 patients wit...
  Turrisi AT, Glover DJ, Mason B, Tester W, ASCO, Vol 21:292
• Combined modality therapy for limited small cell lung cancer.
  Turrisi AT, 2nd IASLC Workshop: Combined radiotherapy & chemotherapy modalities in lung cancer, Fontainebleau, France
• Results of high dose thoracic irradiation (RT) using computed tomography (CT)-based treatment planning and beams eye view (BEV) display in non-small cell lung cancer (...
  Hazuka MB, Lutz ST, Turrisi AT, Martel MK, TenHaken RK, Borema LP, Lichter AS, ASTRO
• Use of Veff and Iso-Ntcp in the implementation of dose escalation protocols.
  TenHaken RK, Martel MK, Kessler ML, Hazuka MB, Lawrence TS, Robertson JM, Turrisi AT, Lichter AS, ASTRO
• Dose-column histogram and 3-D treatment planning evaluation of patients with pneumonitis.
  Martel MK, TenHaken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS, ASTRO
• Morbidity as a function of fractionation in combined-modality therapy of esophageal cancer: Analysis of toxicity frequency and partial organ tolerance.
  Sahijdak WM, Turrisi AT, Martel MK, TenHaken RK, Marsh CMD, Lichter AS, et al, Radiology RSNA '92 Scientific Program 185(P):374
• Patterns of failure and second malignancies from SWOG-8269: concurrent cisplatin (P), etoposide (E), vincristine (V), and once daily radiotherapy (RT) for the treatme...
  Janaki L, Rector D, Turrisi A, McCracken J, Livingston R, Giri S, Gordon W, Crowley J, for the Southwest Oncology Group, Proceedings of Amer Soc Clin Oncol 13:331
• Cisplatin (P) & etoposide (E) + concurrent thoracic radiotherapy (TRT) administered once versus twice daily for limited-stage (LS) small cell lung cancer (SCLC): Prel...
  Johnson DH, Kim K, Turrisi AT, Sause W, Wagner H, Blum R, for the Eastern Cooperative Oncology Group, Proceedings of Amer Soc Clin Oncol 13:333
• Long term follow-up (F/U) from SWOG 8269: Concurrent cisPlatin (P), etoposide (E), Vincristine (V) and daily thoracic radiotherapy (TRT) for the treatment of limited ...
  Turrisi AT, Rector D, Janaki LM, McCracken JD, Livingston R, Giri SP, Gordon W, Crowley J, from the Southwest Oncology Group, Lung Cancer 11(1):172
• A preliminary report: Concurrent twice-daily radiotherapy plus Platinum-Etoposide chemotherapy for limited small cell lung cancer.
  Turrisi AT, Glover DJ, Mason BA, Int J Rad Oncol Biol Phys 15:183-187
• Daily (QD) v twice-daily (BID) thoracic irradiation (TI) with concurrent cisplatin-etoposide (PE) for limited small cell lung cancer (LSCLC). Preliminary Results on 3...
  Turrisi AT, Kim K, Johnson DH, Komaki R, Sause W, Curran W, Livingston R, Wagner H, Blum R, for the Eastern Cooperative Oncology Group, Lung Cancer 11(1):172
• Re-irradiation of non-small cell lung cancer.
  Littles JF, Turrisi AT, Hazuka MB, Massey V, Martel M, Lung Cancer 11(1):139
• Concurrent cisplatin/etoposide (PE) + chest radiation (CRT) followed by surgery for stages 3A(N2) and 3B non-small cell lung cancer: completed analysis of SWOG-8805.
  Albain K, Rusch V, Crowley J, Turrisi A, Rice T, Livingston R, Proceedings of Amer Soc Clin Oncol 13:337
• Analysis of localization errors in the definition of the mantle field using a beam's-eye-view treatment planning system.
  Naida JD, Eisbruch A, Sandler HM, Turrisi AT, Schoeppel SL, Lichter AS, Int J Radiat Oncol Biol Phys 30 (suppl 1): 167
• Endobronchial ultrasound-guided needle aspiration. An improved method for diagnosing intrathoracic lymphadenopathy.
  Shannon J, Becker F, Orens J, Bude R, Rubin J, Whyte R, Turrisi A, Martinez F, Lung Cancer 11(1):75
• Estimation of tumor control probability model parameters from a database of 3-D dose distributions of non small cell lung cancer patients.
  Martel MK, TenHaken RK, Hazuka MB, Kessler ML, Turrisi AT, Fraass BA, Lung Cancer 11(1):183
• A phase I-II study of daily carboplatin and simultaneous accelerated hyperfractionated chest irradiation followed by carboplatin in patients with regionally inoperable...
  Kelly K, Bunn PA, Hazuka M, Turrisi A, Lung Cancer 11(1):179
• Join now to see all

Lectures

• Role of Radiation Therapy in Non-Small Cell Lung Cancer. 
  55th Annual Midwinter Radiation Oncology Conference, Los Angeles, CA
• Controversies with Dose, Volume, Fractions of Radiotherapy in Combination with Chemotherapy for Non-Small Cell Lung Cancer. 
  2nd International Lung Cancer Congress, Kauai, Hawaii
• PCI in Small Cell and Non-Small Cell Lung Cancer. 
  55th Annual Midwinter Radiation Oncology Conference, Los Angeles, CA
• Role of Radiation Therapy in Small Cell Lung Cancer. 
  55th Annual Midwinter Radiation Oncology Conference, Los Angeles, CA
• Radiation Therapy in Lung Cancer. 
  New York Cancer Society/New York Lung Cancer Alliance, New York, NY
• Proper Management of State IIIA Non-small Cell Lung Cancer: Facts and Fantasies. 
  14th Annual Pittsburgh Cancer Conference, Pittsburgh, PA
• Lung Cancer, Part II: Small Cell Lung Cancer. 
  ASTRO, San Francisco, CA
• What’s New in the Role of VRT in Lung Cancer in 2004. 
  New Hanover Regional Medical Center, Wilmington, NC
• The Spectrum of Radiotherapy Roles: Curative, Palliative and Prophylactic. 
  14th Annual Lung Cancer Symposium, Cincinnati, OH
• Surgery as Multimodality”, Are More Aggressive Therapies Able to Improve Treatment of locally Advanced NSCLC. 
  St. Thomas, VI
• Non Small Cell Lung Cancer – Chemoradiotherapy. 
  Florida Hospital, Orlando, FL
• Controversies in the Treatment of Stage III non-small cell lung cancer. 
  Catholic University, Rome, Italy
• Future Applications of TomoTherapy in the Thorax. 
  TomoTherapy’s Image Guided IMRT Conference, Shreveport, LA
• Advances in the Management of Lung Cancer. 
  Lung Cancer Symposium, West Allis Memorial Hospital, Milwaukee, WI
• Non Small Cancer of the Lung. 
  Sierra Providence Health Network’s 22nd Annual Western Regional Oncology Conference, El Paso, TX
• Small Cell Cancer of the Lung. 
  Sierra Providence Health Network’s 22nd Annual Western Regional Oncology Conference, El Paso, TX
• Symptom Management in Cancer: Pain, Depression, and Fatigue. 
  Bethesda, MD
• 3-D treatment Planning for Prostate Cancer. 
  Charleston, SC
• Combined modality therapy of small cell lung cancer. 
  1st Annual Symposium on Concomitant Chemoradiotherapy, Nashville, TN
• Role of radiotherapy in the management of small-cell lung cancer. 
  ASTRO Annual Meeting, New Orleans, LA
• Combined Treatment. 
  4th Annual Coastal Oncology Symposium, Wrightsville Beach, NC
• Combined Modality Non-Cell and Small Cell Lung Carcinoma. 
  4th Annual Coastal Oncology Symposium, Wrightsville Beach, NC
• The SORTIE Trial: Palliation with Stent or Radiation Therapy 20 Gy in 5 fractions Intervention for Esophageal Cancer Sysphagia: A multicenter trial for T-4, M+/- Squ... 
  ASTRO Annual Meeting, New Orleans, LA
• Pre-operative Radiation Therapy and Chemotherapy. 
  4th Annual Coastal Oncology Symposium, Wrightsville Beach, NC
• Modern Approaches to Management. 
  ASCO Pan Asia Cancer Conference, New Delhi, India
• Join now to see all